Style | Citing Format |
---|---|
MLA | Nouri K, et al.. "Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model." Hepatobiliary and Pancreatic Diseases International, vol. 24, no. 1, 2025, pp. 92-103. |
APA | Nouri K, Piryaei A, Seydi H, Zarkesh I, Ghoytasi I, Shokouhian B, Najimi M, Vosough M (2025). Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model. Hepatobiliary and Pancreatic Diseases International, 24(1), 92-103. |
Chicago | Nouri K, Piryaei A, Seydi H, Zarkesh I, Ghoytasi I, Shokouhian B, Najimi M, Vosough M. "Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model." Hepatobiliary and Pancreatic Diseases International 24, no. 1 (2025): 92-103. |
Harvard | Nouri K et al. (2025) 'Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model', Hepatobiliary and Pancreatic Diseases International, 24(1), pp. 92-103. |
Vancouver | Nouri K, Piryaei A, Seydi H, Zarkesh I, Ghoytasi I, Shokouhian B, et al.. Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model. Hepatobiliary and Pancreatic Diseases International. 2025;24(1):92-103. |
BibTex | @article{ author = {Nouri K and Piryaei A and Seydi H and Zarkesh I and Ghoytasi I and Shokouhian B and Najimi M and Vosough M}, title = {Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model}, journal = {Hepatobiliary and Pancreatic Diseases International}, volume = {24}, number = {1}, pages = {92-103}, year = {2025} } |
RIS | TY - JOUR AU - Nouri K AU - Piryaei A AU - Seydi H AU - Zarkesh I AU - Ghoytasi I AU - Shokouhian B AU - Najimi M AU - Vosough M TI - Fibrotic Liver Extracellular Matrix Induces Cancerous Phenotype in Biomimetic Micro-Tissues of Hepatocellular Carcinoma Model JO - Hepatobiliary and Pancreatic Diseases International VL - 24 IS - 1 SP - 92 EP - 103 PY - 2025 ER - |